XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jul. 01, 2023
Jul. 02, 2022
Jul. 01, 2023
Jul. 02, 2022
Operating activities        
Net earnings (loss) $ (18,838) $ 1,471 $ (17,461) $ 6,039
Earnings (loss) from discontinued operations 0 (814) 0 2,752
Earnings (loss) from continuing operations (18,838) 2,285 (17,461) 3,287
Items not affecting cash:        
Depreciation and amortization 10,787 9,372 20,785 18,785
Amortization of debt issuance costs 388 396 795 771
Deferred income taxes 8,828 2,341 3,978 2,163
Stock-based compensation 2,029 3,970 5,921 5,599
Other (97) 1,634 506 1,745
Changes in operating assets and liabilities 12,781 (22,452) 5,221 (19,261)
Net cash provided by (used in) operating activities of continuing operations 15,878 (2,454) 19,745 13,089
Investing activities        
Additions to property, plant and equipment (8,057) (37,038) (33,899) (62,760)
Proceeds from sale of sunflower business 0 0 385 0
Proceeds from sale of property, plant and equipment 0 2,978 0 4,182
Net cash used in investing activities of continuing operations (8,057) (34,060) (33,514) (58,578)
Net cash used in investing activities of discontinued operations 0 (6,324) 0 (6,324)
Net cash used in investing activities of continuing operations (8,057) (40,384) (33,514) (64,902)
Financing activities        
Increase (decrease) in borrowings under revolving credit facilities (3,112) 31,067 5,700 20,762
Borrowings of long-term debt 640 18,206 19,333 41,103
Repayment of long-term debt (10,964) (5,174) (21,012) (7,569)
Proceeds from notes payable 24,433 0 35,095 0
Repayment of notes payable (9,935) 0 (15,368) 0
Proceeds from the exercise of stock options and employee share purchases 287 341 576 591
Payment of withholding taxes on stock-based awards (8,758) (882) (9,007) (971)
Payment of cash dividends on preferred stock (305) (609) (1,123) (1,218)
Payment of share issuance costs (36) 0 (123) 0
Payment of debt issuance costs 0 (53) 0 (559)
Net cash provided by (used in) financing activities of continuing operations (7,750) 42,896 14,071 52,139
Increase in cash and cash equivalents in the period 71 58 302 326
Cash and cash equivalent, beginning of the period 910 495 679 227
Cash and cash equivalents, end of the period $ 981 $ 553 $ 981 $ 553